Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atracurium besylate (51W89) is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 30.00 | |
25 mg | In stock | $ 44.00 | |
50 mg | In stock | $ 61.00 | |
100 mg | In stock | $ 102.00 | |
200 mg | In stock | $ 157.00 | |
500 mg | In stock | $ 252.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Atracurium besylate (51W89) is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. |
Synonyms | Tracrium, 51W89, BW-33A |
Molecular Weight | 1243.49 |
Formula | C65H82N2O18S2 |
CAS No. | 64228-81-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL(40.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atracurium besylate 64228-81-5 Neuroscience AChR inflammatory anticancer Inhibitor Tracrium 51W89 neuromuscular blockade inhibit nAChR GSC cells BW-33A Nicotinic acetylcholine receptors bronchoconstriction inhibitor